RATIONALLY DESIGNED BENZYL-N-METHYL)AMINOCARBONYL]-1,3-DIAMINOBENZENE, BIGBEN, BINDS TO THE MINOR-GROOVE OF D(CGCGAATTCGCG)(2) AS DETERMINED BY 2-DIMENSIONAL NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
Cr. Watts et al., RATIONALLY DESIGNED BENZYL-N-METHYL)AMINOCARBONYL]-1,3-DIAMINOBENZENE, BIGBEN, BINDS TO THE MINOR-GROOVE OF D(CGCGAATTCGCG)(2) AS DETERMINED BY 2-DIMENSIONAL NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Journal of the American Chemical Society, 117(40), 1995, pp. 9941-9950
We have used homonuclear NMR techniques to investigate the interaction
s between the de novo designed minor groove ligand N,N'-bis[(N-p-guani
dinobenzyl-N-methyl) aminocarbonyl]-1,3 -diaminobenzene ''BIGBEN'' and
the receptor for which it was designed, the d(CGCGAATTCGCG)(2) dodeca
mer. Our NMR results show unequivocally the interaction between the no
nexchangeable and exchangeable protons of BIGBEN and the minor groove
protons of the dodecamer. These interactions were characterized with t
he use of 1D NMR titrations to establish that the ligand is in fast-ch
emical exchange with the dodecamer on the chemical shift time scale, h
omonuclear NOESY experiments to establish the connectivities between t
he ligand and the DNA, and NOE-assisted computational modeling to deve
lop a structural interpretation of the data. This represents the first
complete iteration of our design cycle applied to the minor groove of
DNA. The cycle begins with the selection of a receptor for which ther
e is high-resolution structural data. A structural database is then se
arched for putative ligands which may have shape complementarity to th
e desired binding site on the receptor. The ligand, or a derivative th
ereof, is synthesized, and its ability to bind to the desired receptor
is tested. The cycle culminates with the characterization of the stru
ctural interactions in the complex, elucidated here for BIGBEN and the
dodecamer d(CGCGAATTCGCG)(2).